Sign up to save your podcasts
Or
Share Biotech Germany: The Qiagen Story with Prof. Riesner (Part 2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biotech Germany: The Qiagen Story with Prof. Riesner (Part 2)
Join us as Professor Detlev Riesner, co-founder of Qiagen, reveals the secrets behind building a global biotech powerhouse. Launching Qiagen in 1980s Germany, a time when venture capital was scarce and the path from research to market success was uncharted, Professor Riesner didnāt just imagine itāhe lived it.
š Vanta automates security and compliance, save 1.000 US$ with us by signing up with this link: vanta.com/startupradio
In this exclusive interview, youāll learn:
The founding story of Qiagen and its groundbreaking achievement as the first German company to list on Nasdaq! š
Professor Riesnerās firsthand account of overcoming early-stage biotech challenges and securing funding.
Key strategies for bridging the gap between academic research and building a thriving business.
Insights into the evolution of Germany's biotech ecosystem and its impact on innovation.
Professor Riesnerās advice for biotech entrepreneurs, tech founders, and investors.
A must-listen for those interested in:
Biotech entrepreneurship and startups
Biotech funding and investment
University spin-offs and technology transfer
Building and scaling successful biotech companies
The history and future of the German biotech industry
Ready to be inspired?
Professor Riesnerās profound insight: "It has to be in the mind of the administration of these people to help and not to ask money from people who don't have the money." This insight encapsulates the challenges and potential of academic entrepreneurship.
Episode Highlights:
The influence of a Nobel laureate on Professor Riesnerās academic journey.
Transitioning from academia to building a biotech company.
Overcoming funding challenges in biotechās early days.
Qiagenās historic Nasdaq listing.
The evolution of Germany's biotech ecosystem.
Professor Riesnerās advice for aspiring biotech entrepreneurs.
Learn more about Professor Detlev Riesner:
Wikipedia: Detlev Riesner
QIAGEN: Prof. Dr. Detlev Riesner in Hall of Fame
Connect with Startuprad.io:
Work with us ā Reach out: [email protected]
Subscribe to our podcast
Give us feedback
Follow our Editor-in-Chief / Founder on LinkedIn
#BiotechEntrepreneurship #BiotechStartups #BiotechInnovation #BiotechFunding #UniversitySpinOffs #Qiagen #GermanBiotech #DACHStartups #AcademicEntrepreneurship #BiotechIndustry #Entrepreneurship #StartupSuccess #BiotechGermany #BiotechHistory #BiotechLeadership #VentureCapital #Nasdaq #Startupradio
Share this episode with your network!
Startuprad.ioā¢ - All Rights Reserved
View all episodes
By [email protected]
5
229229 ratings
Join us as Professor Detlev Riesner, co-founder of Qiagen, reveals the secrets behind building a global biotech powerhouse. Launching Qiagen in 1980s Germany, a time when venture capital was scarce and the path from research to market success was uncharted, Professor Riesner didnāt just imagine itāhe lived it.
š Vanta automates security and compliance, save 1.000 US$ with us by signing up with this link: vanta.com/startupradio
In this exclusive interview, youāll learn:
The founding story of Qiagen and its groundbreaking achievement as the first German company to list on Nasdaq! š
Professor Riesnerās firsthand account of overcoming early-stage biotech challenges and securing funding.
Key strategies for bridging the gap between academic research and building a thriving business.
Insights into the evolution of Germany's biotech ecosystem and its impact on innovation.
Professor Riesnerās advice for biotech entrepreneurs, tech founders, and investors.
A must-listen for those interested in:
Biotech entrepreneurship and startups
Biotech funding and investment
University spin-offs and technology transfer
Building and scaling successful biotech companies
The history and future of the German biotech industry
Ready to be inspired?
Professor Riesnerās profound insight: "It has to be in the mind of the administration of these people to help and not to ask money from people who don't have the money." This insight encapsulates the challenges and potential of academic entrepreneurship.
Episode Highlights:
The influence of a Nobel laureate on Professor Riesnerās academic journey.
Transitioning from academia to building a biotech company.
Overcoming funding challenges in biotechās early days.
Qiagenās historic Nasdaq listing.
The evolution of Germany's biotech ecosystem.
Professor Riesnerās advice for aspiring biotech entrepreneurs.
Learn more about Professor Detlev Riesner:
Wikipedia: Detlev Riesner
QIAGEN: Prof. Dr. Detlev Riesner in Hall of Fame
Connect with Startuprad.io:
Work with us ā Reach out: [email protected]
Subscribe to our podcast
Give us feedback
Follow our Editor-in-Chief / Founder on LinkedIn
#BiotechEntrepreneurship #BiotechStartups #BiotechInnovation #BiotechFunding #UniversitySpinOffs #Qiagen #GermanBiotech #DACHStartups #AcademicEntrepreneurship #BiotechIndustry #Entrepreneurship #StartupSuccess #BiotechGermany #BiotechHistory #BiotechLeadership #VentureCapital #Nasdaq #Startupradio
Share this episode with your network!
Startuprad.ioā¢ - All Rights Reserved
More shows like šļø Startuprad.ioā¢ ā Europeās Voice on Startups, VC, Innovation & Growth
View all
š³ FinTech Germany ā Startups and Venture Capital
1 Listeners
š Security Sutra ā Cybersecurity Startups and Venture Capital
0 Listeners
Blockchain Germany - Startups and Venture Capital
0 Listeners
š§Ŗ Deep Tech Germany ā Startups and Venture Capital
0 Listeners
Tech Startups Germany - Startups and Venture Capital
0 Listeners
š° Startup & Tech News from Germany, Austria, and Switzerland
0 Listeners
Learn German | Deutsch lernen | ExpertlyGerman Podcast
90 Listeners
Starting Y
0 Listeners
European Startup Pulse
0 Listeners
š©āš Women Who Rock GSA ā A Female Entrepreneurship Podcast
0 Listeners